Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry

JAMA Internal Medicine

Volumn 175, Issue 9, 2015, Pages 1474-1480

  Ageno, Walter ^a   Riva, Nicoletta ^a   Schulman, Sam ^b   Beyer Westendorf, Jan ^c   Bang, Soo Mee ^d   Senzolo, Marco ^e   Grandone, Elvira ^f   Pasca, Samantha ^g   Di Minno, Matteo Nicola Dario ^h,i   Duce, Rita ^j   Malato, Alessandra ^k   Santoro, Rita ^l   Poli, Daniela ^m   Verhamme, Peter ⁿ   Martinelli, Ida ^o   Kamphuisen, Pieter ^p   Oh, Doyeun ^q   D'Amico, Elbio ^r   Becattini, Cecilia ^s   De Stefano, Valerio ^t   Vidili, Gianpaolo ^u   Vaccarino, Antonella ^v   Nardo, Barbara ^w   Di Nisio, Marcello ^x   Dentali, Francesco ^a   more..

^a UNIVERSITY OF INSUBRIA   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d Seoul National University   (South Korea)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^g UNIVERSITY HOSPITAL OF UDINE   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ CENTRO CARDIOLOGICO MONZINO   (Italy)

^j GALLIERA HOSPITAL   (Italy)

^k UNIVERSITY OF PALERMO   (Italy)

^l PUGLIESE CIACCIO HOSPITAL   (Italy)

^m CAREGGI UNIVERSITY HOSPITAL   (Italy)

ⁿ UNIVERSITY OF LEUVEN   (Belgium)

^o FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^p UNIVERSITY OF GRONINGEN   (Netherlands)

^q CHA University   (South Korea)

^r UNIVERSITY OF SÃO PAULO   (Brazil)

^s UNIVERSITY OF PERUGIA   (Italy)

^t CATHOLIC UNIVERSITY   (Italy)

^u UNIVERSITY HOSPITAL OF SASSARI   (Italy)

^v MOLINETTE HOSPITAL   (Italy)

^w BUSTO ARSIZIO HOSPITAL   (Italy)

^x UNIVERSITY OF CHIETI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL SURGERY; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; COHORT ANALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE INFARCTION; LIVER CIRRHOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN THROMBOSIS; MIDDLE AGED; MYELOPROLIFERATIVE NEOPLASM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SOLID TUMOR; SPLANCHNIC VEIN THROMBOSIS; SUDDEN DEATH; TREATMENT DURATION; VEIN THROMBOSIS; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPLICATION; MORTALITY; MULTICENTER STUDY; RECURRENT DISEASE; REGISTER; SPLANCHNIC BLOOD FLOW; VENOUS THROMBOSIS;

ADULT; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; SPLANCHNIC CIRCULATION; VENOUS THROMBOSIS;

EID: 84941241831     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.3184     Document Type: Article

References (13)

1. Ageno W, Dentali F, Squizzato A. How I treat splanchnic vein thrombosis. Blood. 2014;124(25):3685-3691.
2. Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol. 2010;8(2):200-205.
3. Darwish Murad S, Plessier A, Hernandez-Guerra M, et al; EN-Vie (European NetworkforVascular Disorders of the Liver). Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151(3):167-175.
4. Ageno W, Riva N, Schulman S, et al; IRSVTStudy Group. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry. Semin Thromb Hemost. 2014;40(1):99-105.
5. Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120(2):490-497.
6. Spaander MCW, Hoekstra J, Hansen BE, Van Buuren HR, Leebeek FW, Janssen HLA. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J Thromb Haemost. 2013;11(3):452-459.
7. Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al; European Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51(1):210-218.
8. De Leve LD, Valla DC, Garcia-Tsao G; American Association for the Study of Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49(5):1729-1764.
9. Kearon C, Akl EA, Comerota AJ, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S-e494S. doi:10.1378/chest.11-2301.
10. Lecumberri R, Alfonso A, Jiménez D, et al; RIETE investigators. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. Thromb Haemost. 2013;110(4):834-843.
11. Iorio A, Kearon C, Filippucci E, et al. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch Intern Med. 2010;170(19):1710-1716.
12. Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692-694.
13. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100(10):3484-3488.